Congenital Hemophilia A and B are bleeding disorders that are caused by genetic X-linked deficiencies in the blood clotting Factors VIII and IX, respectively. Hemophilia manifests as mild, moderate, or severe inability to form clots, depending upon the endogenous levels of circulating factor in an individual patient.

Acquired Hemophilia

Global Hemophilia A Drug Market Forecasts to 2021

Hemophilia A Market Size, Share, Analysis and Outlook 2016

Hemophilia A And B Asia-Pacific Market Will Be Valued At $699.1m And $112.9m Respectively In 2022

Hemophilia A Market Size, Share, Trends and Analysis

Gastric and Gastroesophageal Junction Adenocarcinoma Market Growth, Trends, Analysis and Forecast

US Green Building Material Market

Point of Care Testing Market Review, Outlook, Overview And Forecasts to 2020

Water Treatment Systems Market Size 2016 - 2024

Server Market Insights, Trends, Growth, Analysis and Forecasts, 2016-2020

Food Security Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

United Kingdom Crude Oil Refinery Market Growth, Size, Share and Forecast to 2021